Profitability Metrics

Gross Margin
33.19%
Operating Margin
0.00%
Net Margin
-6.42%

Efficiency Metrics

Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
4.40%
Income Tax Rate
6,480,000,000.0%
EPS
-2.9000000000

Balance Sheet Analysis

Current Ratio
1.74
Cash Ratio
0.68
Working Capital
$433.90M
Debt to Equity
0.82
Debt to Assets
27.80%
Equity Ratio
33.84%

Cash Flow Analysis

Operating Cash Flow Ratio
5.62%
Free Cash Flow Ratio
4.82%
CapEx to Revenue
0.80%
Dividends Paid
$52.60M
Stock Buybacks
No buybacks
Total Shareholder Returns
$52.60M
Cash Position Change
606.90%

Key Takeaways (2024 FY)

  • Increased dividend payments by 1.09%

Detailed Growth Metrics

Core Performance

Revenue
12.63%
Net Income
-135.84%
EPS
-135.54%
Operating Income
-100.00%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-100.00%
Operating Cash Flow
-7.58%
Free Cash Flow
-0.44%

Balance Sheet Health

Assets
-5.57%
Debt
-92.29%
Book Value per Share
-13.10%
Inventory
-11.37%

Shareholder Returns

Dividends per Share
1.09%
Shares Outstanding
0.86%

Long Term Trends

3Y Revenue/Share
18.20%
5Y Revenue/Share
57.35%
3Y Dividend/Share
3.90%
5Y Dividend/Share
6.16%